NewslettersHuman Immunology NewsImmune Regulation News Quoin Pharmaceuticals Enters Exclusive Research Agreement for Scleroderma Treatment with Australian University By Danielle Corrigan - May 27, 2022 0 Quoin Pharmaceuticals Ltd. announced it has signed a second, exclusive research agreement with the Queensland University of Technology, Australia. [Quoin Pharmaceuticals, Ltd.] Press Release